The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of incretin mimetic therapy on weight change in patients with cancer: A pan-cancer analysis from a single institutional cohort.
 
Yan Leyfman
No Relationships to Disclose
 
Alyssa Carlson
No Relationships to Disclose
 
Sherry Shen
Honoraria - MJH Life Sciences
Research Funding - Merck (Inst); Sermonix Pharmaceuticals (Inst)
 
Andriy Derkach
No Relationships to Disclose
 
Urvi Shah
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); M and M labs (Inst); Sabinsa Corporation (Inst)
 
Neil Iyengar
Consulting or Advisory Role - AstraZeneca; BD Biosciences; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Novartis; Pfizer; Seagen; SynDevRx; Tersera
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst); SynDevRx (Inst)